Abstract

BackgroundAlthough prostate cancer-related incidence and mortality have declined recently, striking racial/ethnic differences persist in the United States. Visualizing and modelling temporal trends of prostate cancer late-stage incidence, and how they vary according to geographic locations and race, should help explaining such disparities. Joinpoint regression is increasingly used to identify the timing and extent of changes in time series of health outcomes. Yet, most analyses of temporal trends are aspatial and conducted at the national level or for a single cancer registry.MethodsTime series (1981-2007) of annual proportions of prostate cancer late-stage cases were analyzed for non-Hispanic Whites and non-Hispanic Blacks in each county of Florida. Noise in the data was first filtered by binomial kriging and results were modelled using joinpoint regression. A similar analysis was also conducted at the state level and for groups of metropolitan and non-metropolitan counties. Significant racial differences were detected using tests of parallelism and coincidence of time trends. A new disparity statistic was introduced to measure spatial and temporal changes in the frequency of racial disparities.ResultsState-level percentage of late-stage diagnosis decreased 50% since 1981; a decline that accelerated in the 90's when Prostate Specific Antigen (PSA) screening was introduced. Analysis at the metropolitan and non-metropolitan levels revealed that the frequency of late-stage diagnosis increased recently in urban areas, and this trend was significant for white males. The annual rate of decrease in late-stage diagnosis and the onset years for significant declines varied greatly among counties and racial groups. Most counties with non-significant average annual percent change (AAPC) were located in the Florida Panhandle for white males, whereas they clustered in South-eastern Florida for black males. The new disparity statistic indicated that the spatial extent of racial disparities reached a peak in 1990 because of an early decline in frequency of late-stage diagnosis observed for black males.ConclusionsAnalyzing temporal trends in cancer incidence and mortality rates outside a spatial framework is unsatisfactory, since it leads one to overlook significant geographical variation which can potentially generate new insights about the impact of various interventions. Differences observed among nested geographies in Florida show how the modifiable areal unit problem (MAUP) also impacts the analysis of temporal changes.

Highlights

  • Prostate cancer-related incidence and mortality have declined recently, striking racial/ ethnic differences persist in the United States

  • Cancer specialists remain deeply divided over the effectiveness of the Prostate Specific Antigen (PSA) blood tests as a diagnostic tool for prostate cancer, some mathematical models projected that 45% to 70% of the observed decline in prostate cancer mortality could be plausibly attributed to the stage shift induced by PSA screening [7]

  • This paper demonstrates how to apply the popular joinpoint regression approach at three different geographically nested levels: State, groups of metropolitan and non-metropolitan counties, and individual counties

Read more

Summary

Introduction

Prostate cancer-related incidence and mortality have declined recently, striking racial/ ethnic differences persist in the United States. Visualizing and modelling temporal trends of prostate cancer latestage incidence, and how they vary according to geographic locations and race, should help explaining such disparities. Inequity in overall cancer survival by race is recognized and attributed to differences in the stage at which cancer is diagnosed, its treatment, and, to a lesser extent, in the aggressiveness of tumors. Cancer specialists remain deeply divided over the effectiveness of the PSA blood tests as a diagnostic tool for prostate cancer, some mathematical models projected that 45% to 70% of the observed decline in prostate cancer mortality could be plausibly attributed to the stage shift induced by PSA screening [7]. Other studies found that racial disparity in PSA testing is probably not a major factor behind current racial differences in prostate cancer mortality rates and declines [8]. If we cannot explain the observed patterns, our knowledge is likely incomplete and our interventions potentially misguided”

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call